Samuel Broder's most recent trade in Sensei Biotherapeutics Inc was a trade of 14,550 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 10, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Samuel Broder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 14,550 | 14,550 | - | - | Stock Option (Right to Buy) | |
| Sensei Biotherapeutics Inc | Samuel Broder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 4,466 | 8,932 | - | 0 | Common Stock | |
| Sensei Biotherapeutics Inc | Samuel Broder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 14,550 | 14,550 | - | - | Stock Option (Right to Buy) | |
| Sensei Biotherapeutics Inc | Samuel Broder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,466 | 4,466 | - | 0 | Common Stock |